Bioavailability of two single-dose oral formulations of omeprazole 20 mg: an open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteers.

@article{Poo2008BioavailabilityOT,
  title={Bioavailability of two single-dose oral formulations of omeprazole 20 mg: an open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteers.},
  author={Jorge Luis Poo and Juan Francisco Gal{\'a}n and Alejandra Rosete and Alberto de Lago and Iv{\'a}n Oliva and Mario Gonz{\'a}lez-de la Parra and Patr{\'i}cia Jim{\'e}nez and Victoria Burke-Fraga and Salvador Namur},
  journal={Clinical therapeutics},
  year={2008},
  volume={30 4},
  pages={693-9}
}
BACKGROUND Omeprazole is a proton-pump inhibitor that acts to reduce acid secretion in the stomach and is used for treating various acid-related gastrointestinal disorders. There are several generic formulations of omeprazole available in Mexico; however, a literature search failed to identify published data concerning the bioavailability of these formulations in the Mexican population. OBJECTIVE The aim of this study was to compare the bioavailability of 2 oral formulations of omeprazole 20… CONTINUE READING